Superoxide dismutase (SOD) vs placebo
Mortality before hospital discharge · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes mortality prior to discharge№ of participants: 78(2 RCTs) compared with placebo (very low certainty).
1 finding from 1 review
- Superoxide dismutase for bronchopulmonary dysplasia in preterm infants 2023 · Cochrane Headline outcomes onlyRR 1.2 [0.53, 2.71]Studies not reportedVery low